Notice of Effectiveness

Arcadia Biosciences, Inc. Filed 2019-08-27 Acc 9999999995-19-001969

Documents 1

2019-12-20 EFFECT Notice of Effectiveness
2019-08-28 8-K Executive or director change
2019-08-28 4/A Chief Financial Officer bought 8,000 shares at an average $8.73 ($69,860)
2019-08-28 4 Chief Financial Officer acquired 8,000 shares (grant or award)
2019-08-27 EFFECT Notice of Effectiveness
2019-08-26 CORRESP Correspondence Between Filers and SEC Staff
2019-02-14 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…